Clinical Trials Directory

Trials / Completed

CompletedNCT06010017

Peer Support Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation

Peer Support Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation (STEPP): Feasibility and Preliminary Efficacy Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
136 (actual)
Sponsor
Brigham and Women's Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main purpose of this study is to determine if a novel peer support intervention (STEPP) is feasible among patients undergoing hematopoietic stem cell transplantation (HSCT). The name of the intervention used in this research study is STEPP, a peer support intervention comprised of five learning modules on psychoeducation and supportive psychotherapy strategies, tailored to the unique needs of patients undergoing HSCT.

Detailed description

The goal of this project is to refine a peer support intervention (STEPP) for patients undergoing hematopoietic stem cell transplantation (HSCT) and to conduct a randomized clinical trial to test its feasibility and preliminary efficacy for improving quality of life (QOL) and reducing psychological distress. Participants will be randomized into one of two study groups: Peer Support Intervention (STEPP) vs. Usual Care. Randomization means a participant is placed into a group by chance. Participants will have an equal chance of being placed in either group. Study procedures include screening for eligibility and questionnaires. Participation in this study is expected to last about 10 weeks. It is expected that about 80 people will participate in this randomized clinical trial.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSTEPP InterventionPeer support intervention comprised of five learning modules on psychoeducation and supportive psychotherapy strategies, via virtual platform. If participants do not have a smart device, one will be provided by the study team.

Timeline

Start date
2024-02-20
Primary completion
2025-03-03
Completion
2025-03-21
First posted
2023-08-24
Last updated
2025-08-05

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06010017. Inclusion in this directory is not an endorsement.